TheEdgeResearch
Home / Stocks / VRCI

Verde Science, Inc. (VRCI)

OTC Healthcare Biotechnology
$0.00 ▲ +0.00%
Market Cap
$477
Sector
Healthcare
Industry
Biotechnology
Beta
-6.16
52-Wk Range
0.000001-0.00002
CEO
Harpreet Singh Sangha
Country
US
Currency
USD

Verde Science, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $477. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of -6.16 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-0.12
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.29
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2009-02-10
Headquarters
Dallas, TX, US
About Verde Science, Inc.

Verde Science, Inc., a pharmaceutical research and development enterprise, is dedicated to advancing a diverse array of prescription medications derived from cannabinoids, intended for the treatment of numerous health conditions. The company, which initially operated as Rango Energy, Inc., officially transitioned to the name Verde Science, Inc. in May 2014. Established in 2007, the company maintains its operational headquarters in Dallas, Texas.

Comparable companies

Verde Science, Inc. is most often compared with the following Healthcare names:

BIOCQBSPMCLVRCRFTFELOXHTGMQMICRDNBRVFNEXINMSCA
More research on VRCI
VRCI technical analysis VRCI TheEdge Score Compare against peers
Open full interactive analysis & DCF →